The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of mexican population: a preliminary report
Open accessAbstract
Background: Spirulina maxima is a filamentous cyanobacterium used as food supplement because of its high nutrient contents. It has been experimentally proven, in vivo and in vitro that posses several pharmacological properties. The purpose of this study was to evaluate the effects of Spirulina maxima orally supplied (4.5 g/day, for 6 weeks) to a sample of 36 subjects (16 men and 20 women, with ages between 18–65 years) on serum lipids, glucose, aminotransferases and on blood pressure. The volunteers did not modify their dietary habits or lifestyle during the whole experimental period. From each subject, a sample of blood was drawn in fasting state of 12 hours to determi the plasma concentrations of glucose, triacylglycerols (TAG), total cholesterol (TC), cholesterol associated to high density lipoprotein (HDL-C) and aspartate aminotransferase (AST). Anthropometric measurements including systolic (SYST-P) and diastolic (DIAST-P) blood pressure, height, weight and Body Mass Index (BMI) were also recorded. Results: Comparing initial and final data, the results showed that there were no significant changes in the values of glucose and AST, but significant differences in TAG, TC, and HDL-C, were observed: TAG 233.7 ± 177.8 vs. 167.7 ± 100.7 mg/dL (p < 0.001), TC 181.7 ± 37.5 vs. 163.5 ± 34.4 mg/dL (p < 0.001), C-HDL 43.5 ± 14.4 vs. 50 ± 18.8 mg/dL (p < 0.01). The univariated analysis showed that the changes in the HDL-C and TC concentrations were dependent on TAG concentration (p = 0.247 and p = 0.108, respectively); nevertheless the calculated values for cholesterol associated to low density lipoprotein (LDL-C) were significantly reduced by the Spirulina maxima treatment but independently of the TAG changes. In addition, significant differences were found comparing initial and final SYST-P and DIAST-P blood pressure in both male and female: SYST-P male 121 ± 9 vs. 111 ± 8 mm Hg (p < 0.01), DIAST-P male 85 ± 6.5 vs. 77 ± 9 mm Hg (p < 0.01); SYST-P female 120 ± 9.5 vs. 109 ± 11 mm Hg (p < 0.002), DIAST-P female 85 ± 11 vs. 79 ± 7.5 mm Hg (p < 0.03). Conclusion: The Spirulina maxima showed a hypolipemic effect, especially on the TAG and the LDL-C concentrations but indirectly on TC and HDL-C values. It also reduces systolic and diastolic blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Spirulina presents hypolipidemic [11], hypoglycemic [12], and antihypertensive [13] properties.”
From Antioxidant, Immunomodulating, and Microbial‐Modulating Activities of the Sustainable and Ecofriendly Spirulina (2017) · cites this paper as [13]
In the citing paper
“In overweight subjects [13] and in T2D patients with dyslipidemia [106] the improvement in the lipid profile was accompanied by a reduction of blood pressure.”
From Antioxidant, Immunomodulating, and Microbial‐Modulating Activities of the Sustainable and Ecofriendly Spirulina (2017) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Spirulina, the edible microorganism.
Ciferri, O. (1983) · Microbiological Reviews · doi:10.1128/mmbr.47.4.551-578.1983 · Cited by 745
Nutritional and therapeutic potential of spirulina
Khan, Z., Bhadouria, P., & Bisen, P. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/138920105774370607 · Cited by 524
High-Density Lipoprotein as a Therapeutic Target: A Systematic Review
Singh, I. M., Shishehbor, M. H., & Ansell, B. J. (2007) · JAMA · doi:10.1001/jama.298.7.786 · Cited by 468
Genetic and Environmental Contributions to Cardiovascular Risk Factors in Mexican Americans
Mitchell, B. D., Kammerer, C. M., Blangero, J., Mahaney, M. C., Rainwater, D. L., Dyke, B., Hixson, J. E., Henkel, R. D., Sharp, R. M., Comuzzie, A. G., et al. (1996) · Circulation · doi:10.1161/01.cir.94.9.2159 · Cited by 364
DeLong, D. M. (1986) · JAMA · doi:10.1001/jama.256.17.2372 · Cited by 349
Hayashi (1996) · doi:10.1089/aid.1996.12.1463 · Cited by 320
Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
Gille, A., Bodor, E. T., Ahmed, K., & Offermanns, S. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094746 · Cited by 316
Research works printed but not linked: 3
- Kato T, Takemoto K: Effects of Spirulina on hypercholesterolemia and fatty liver in rats. Japan Nutr Foods Assoc J. 1984, 37: 321-
- Olaiz-Fernandez G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, Villalpando-Hernandez S, Hernandez-Avila M, Sepulveda-Amor J, : Mexican National Health and Nutrition Survey 2006. 2006, Cuernavaca, Mexico: National Public Health Institute.
- Chamorro G, Salazar M, Salazar S: Estudio teratogenico de Spirulina en rata. Arch Latinoam Nutr. 1989, 29: 641-649.
Cited by
Sorted by citations
Microalgae: A potential alternative to health supplementation for humans
Koyande, A. K., Chew, K. W., Rambabu, K., Tao, Y., Chu, D.-T., & Show, P.-L. (2019) · Food Science and Human Wellness · doi:10.1016/j.fshw.2019.03.001 · Cited by 908
Biologically Active Metabolites Synthesized by Microalgae
de Morais, M. G., Vaz, B. D. S., de Morais, E. G., & Costa, J. A. V. (2015) · BioMed Research International · doi:10.1155/2015/835761 · Cited by 492
Hypolipidemic, Antioxidant, and Antiinflammatory Activities of Microalgae Spirulina
Deng, R., & Chow, T. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00200.x · Cited by 435
Finamore, A., Palmery, M., Bensehaila, S., & Peluso, I. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3247528 · Cited by 256
Functional ingredients from microalgae
Buono, S., Langellotti, A. L., Martello, A., Rinna, F., & Fogliano, V. (2014) · Food & Function · doi:10.1039/c4fo00125g · Cited by 254
Metadata
- Authors
- Torres-Duran, P. V., Ferreira-Hermosillo, A., & Juarez-Oropeza, M. A.
- Venue
- Lipids in Health and Disease
- Published
- 2007-11-26
- Volume
- 6
- Issue
- 1
- Pages
- 33-33
- ISSN
- 1476-511X (ISSN-L)
- PMC
- PMC2211748
- OpenAlex
- W2019647669
- Cited by
- 181
- References
- 57
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 12 · 2023: 9 · 2022: 13 · 2021: 8 · 2020: 23 · 2019: 10 · 2018: 14 · 2017: 12 · 2016: 12 · 2015: 11 · 2014: 7 · 2013: 10 · 2012: 2
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Lipids in Health and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Greater South Information System
- Topics
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Natural Products and Biological Research
- Physical Sciences › Energy › Renewable Energy, Sustainability and the Environment › Algal biology and biofuel production
- Keywords
- Spirulina maxima, cyanobacteria, dietary supplementation, hyperlipidemia, hypertension, serum lipids, HDL cholesterol, LDL cholesterol, triglycerides, blood pressure, aspartate aminotransferase, glucose, body mass index, Mexican population, hypolipidemic effect, antihypertensive effect, sex differences, body composition, anthropometry
- MeSH terms
- Adolescent, Adult, Aged, Antihypertensive Agents, Hypolipidemic Agents, Blood Pressure, Female, Humans, Hypertension, Cholesterol, HDL, Cholesterol, LDL, Male, Mexico, Middle Aged, Triglycerides, Prevalence, Dietary Supplements, Dyslipidemias, Spirulina
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
